Screening for the metabolic syndrome in community psychiatric patients prescribed antipsychotics: a quality improvement programme - Barnes, T. R. E.; Paton, C.; Hancock, E.; Cavanagh, M.-R.; Taylor, D.; Lelliott, P. (Acta psychiatrica Scandinavica, 2008)
Keywords: Adolescent; Adult; Aged; Antipsychotic Agents - adverse effects; Antipsychotic Agents - therapeutic use; antipsychotics; Benchmarking - standards; Biological and medical sciences; Body Weight - drug effects; Community Mental Health Services - standards; Community-Institutional Relations - standards; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug toxicity and drugs side effects treatment; England; Female; Health Services Accessibility; Humans; Life Style; Male; Mass Screening - standards; Medical Audit - standards; Medical sciences; Medical screening; Mental disorders; Metabolic syndrome; Metabolic Syndrome - chemically induced; Metabolic Syndrome - diagnosis; Metabolic Syndrome - epidemiology; Middle Aged; Miscellaneous (drug allergy, mutagens, teratogens...); Mood Disorders - drug therapy; Mood Disorders - epidemiology; Pharmacology. Drug treatments; Physical Examination; Psychiatry; Psychotic Disorders - drug therapy; Psychotic Disorders - epidemiology; Quality Assurance, Health Care - standards; Quality Indicators, Health Care - standards; Quality of care; Reference Standards; Reminder Systems; Retrospective Studies; screening; Surveys and Questionnaires; United Kingdom; Europe; United Kingdom--UK; Endocrinopathy; Social environment; Human; Sanitary program; screening; Psychotropic; Neuroleptic; Toxicity; Mental health; Pharmacotherapy; Metabolic diseases; Cardiovascular disease; Medical screening; Metabolic syndrome; Audit; Treatment; Follow up study; Mental disorder; antipsychotics; Community treatment; Public health